BR9913490A - Prosaposina cìclicos e seus usos - Google Patents
Prosaposina cìclicos e seus usosInfo
- Publication number
- BR9913490A BR9913490A BR9913490-0A BR9913490A BR9913490A BR 9913490 A BR9913490 A BR 9913490A BR 9913490 A BR9913490 A BR 9913490A BR 9913490 A BR9913490 A BR 9913490A
- Authority
- BR
- Brazil
- Prior art keywords
- cyclic
- prosaposine
- derived
- peptides
- saposin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Ophthalmology & Optometry (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
"PEPTìDIOS DERIVADOS DE PROSAPOSINA CìCLICOS E SEUS USOS" A invenção se refere a peptídios cíclicos derivados de saposina C que apresentam efeitos neurotróficos e analgésicos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9835998P | 1998-08-28 | 1998-08-28 | |
PCT/US1999/019378 WO2000012553A1 (en) | 1998-08-28 | 1999-08-20 | Cyclic prosaposin-derived peptides and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9913490A true BR9913490A (pt) | 2001-09-25 |
Family
ID=22268937
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9913490-0A BR9913490A (pt) | 1998-08-28 | 1999-08-20 | Prosaposina cìclicos e seus usos |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP1105420A1 (pt) |
JP (2) | JP4528443B2 (pt) |
KR (1) | KR20010079695A (pt) |
CN (1) | CN1324367A (pt) |
AU (1) | AU751034B2 (pt) |
BR (1) | BR9913490A (pt) |
CA (1) | CA2341810A1 (pt) |
CZ (1) | CZ2001655A3 (pt) |
HU (1) | HUP0103265A3 (pt) |
IL (1) | IL141586A0 (pt) |
PL (1) | PL204359B1 (pt) |
WO (1) | WO2000012553A1 (pt) |
ZA (1) | ZA200102489B (pt) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5571787A (en) | 1993-07-30 | 1996-11-05 | Myelos Corporation | Prosaposin as a neurotrophic factor |
PL204359B1 (pl) * | 1998-08-28 | 2010-01-29 | Myelos Corp | Cykliczne peptydy, zawierająca je kompozycja farmaceutyczna i ich zastosowania |
AUPQ084899A0 (en) * | 1999-06-08 | 1999-07-01 | University Of Melbourne, The | Neurotrophin agonists |
IL137820A (en) * | 2000-08-10 | 2009-06-15 | S I S Shulov Inst For Science | Pharmaceutical composition for topical administration comprising an analgesic peptide |
CN100366286C (zh) * | 2003-04-28 | 2008-02-06 | 常州南云科技有限公司 | Saposin C-DOPS:一种抗癌新药 |
EP2020988B1 (en) | 2006-04-28 | 2017-08-16 | Children's Hospital Medical Center | Compositions comprising fusogenic proteins or polypeptides derived from prosaposin for application in transmembrane drug delivery systems |
JP5253402B2 (ja) * | 2006-10-20 | 2013-07-31 | チルドレンズ ホスピタル メディカル センター | 自発的に形成する楕円体の単層リン脂質小胞 |
CN103275187B (zh) * | 2013-06-14 | 2014-10-29 | 四川合泰新光生物科技有限公司 | 一种镇痛肽fi及其基因和应用 |
JP7066412B2 (ja) | 2015-04-23 | 2022-05-13 | ザ プロクター アンド ギャンブル カンパニー | 界面活性剤可溶性抗ふけ剤の送達 |
ES2893974T3 (es) | 2016-03-03 | 2022-02-10 | Procter & Gamble | Composición anticaspa en aerosol |
WO2018075847A1 (en) | 2016-10-21 | 2018-04-26 | The Procter & Gamble Company | Concentrated shampoo dosage of foam designating hair volume benefits |
CN109862944A (zh) | 2016-10-21 | 2019-06-07 | 宝洁公司 | 用于以最佳制剂空间递送消费者所需的剂型体积和表面活性剂量的泡沫剂型 |
WO2018075846A1 (en) | 2016-10-21 | 2018-04-26 | The Procter & Gamble Company | Concentrated shampoo dosage of foam designating hair conditioning benefits |
WO2018075841A1 (en) | 2016-10-21 | 2018-04-26 | The Procter & Gamble Company | Concentrated shampoo dosage of foam for providing hair care benefits |
EP3528897A1 (en) | 2016-10-21 | 2019-08-28 | The Procter & Gamble Company | Dosage of foam for delivering consumer desired dosage volume, surfactant amount, and scalp health agent amount in an optimal formulation space |
EP3528894A1 (en) | 2016-10-21 | 2019-08-28 | The Procter and Gamble Company | Concentrated shampoo dosage of foam for providing hair care benefits |
CA3038128C (en) | 2016-10-21 | 2021-10-12 | The Procter & Gamble Company | Stable compact shampoo products with low viscosity and viscosity reducing agent |
US11224567B2 (en) | 2017-06-06 | 2022-01-18 | The Procter And Gamble Company | Hair compositions comprising a cationic polymer/silicone mixture providing improved in-use wet feel |
US11679073B2 (en) | 2017-06-06 | 2023-06-20 | The Procter & Gamble Company | Hair compositions providing improved in-use wet feel |
US11141370B2 (en) | 2017-06-06 | 2021-10-12 | The Procter And Gamble Company | Hair compositions comprising a cationic polymer mixture and providing improved in-use wet feel |
CN111278417A (zh) | 2017-10-10 | 2020-06-12 | 宝洁公司 | 含低无机盐的无硫酸盐澄清个人清洁组合物 |
JP6952906B2 (ja) | 2017-10-10 | 2021-10-27 | ザ プロクター アンド ギャンブル カンパニーThe Procter & Gamble Company | 泡形態のパーソナルケア組成物で毛髪又は皮膚を処理する方法 |
US11116703B2 (en) | 2017-10-10 | 2021-09-14 | The Procter And Gamble Company | Compact shampoo composition containing sulfate-free surfactants |
JP2020536876A (ja) | 2017-10-10 | 2020-12-17 | ザ プロクター アンド ギャンブル カンパニーThe Procter & Gamble Company | アミノ酸系アニオン性界面活性剤及びカチオン性ポリマーを含むコンパクトシャンプー組成物 |
JP7280265B2 (ja) | 2017-12-20 | 2023-05-23 | ザ プロクター アンド ギャンブル カンパニー | シリコーンポリマーを含有する透明なシャンプー組成物 |
MX2020014144A (es) | 2018-06-29 | 2021-03-25 | Procter & Gamble | Composicion anticaspa en aerosol con bajo contenido de surfactante. |
MX2022005533A (es) | 2019-12-06 | 2022-06-08 | Procter & Gamble | Composicion libre de sulfato con deposito mejorado del activo para el cuero cabelludo. |
JP7481470B2 (ja) | 2020-02-27 | 2024-05-10 | ザ プロクター アンド ギャンブル カンパニー | 有効性及び美観が強化された硫黄含有フケ防止組成物 |
MX2023005963A (es) | 2020-12-04 | 2023-06-07 | Procter & Gamble | Composiciones para el cuidado del cabello que comprenden materiales de reduccion del mal olor. |
US11771635B2 (en) | 2021-05-14 | 2023-10-03 | The Procter & Gamble Company | Shampoo composition |
US11986543B2 (en) | 2021-06-01 | 2024-05-21 | The Procter & Gamble Company | Rinse-off compositions with a surfactant system that is substantially free of sulfate-based surfactants |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6271196B1 (en) * | 1996-03-05 | 2001-08-07 | Regents Of The University Of Ca | Methods of alleviating neuropathic pain using prosaposin-derived peptides |
PL204359B1 (pl) * | 1998-08-28 | 2010-01-29 | Myelos Corp | Cykliczne peptydy, zawierająca je kompozycja farmaceutyczna i ich zastosowania |
-
1999
- 1999-08-20 PL PL346346A patent/PL204359B1/pl not_active IP Right Cessation
- 1999-08-20 BR BR9913490-0A patent/BR9913490A/pt not_active IP Right Cessation
- 1999-08-20 EP EP99943903A patent/EP1105420A1/en not_active Withdrawn
- 1999-08-20 JP JP2000567569A patent/JP4528443B2/ja not_active Expired - Fee Related
- 1999-08-20 HU HU0103265A patent/HUP0103265A3/hu unknown
- 1999-08-20 KR KR1020017002478A patent/KR20010079695A/ko not_active Application Discontinuation
- 1999-08-20 WO PCT/US1999/019378 patent/WO2000012553A1/en not_active Application Discontinuation
- 1999-08-20 CZ CZ2001655A patent/CZ2001655A3/cs unknown
- 1999-08-20 IL IL14158699A patent/IL141586A0/xx not_active IP Right Cessation
- 1999-08-20 CA CA002341810A patent/CA2341810A1/en not_active Abandoned
- 1999-08-20 CN CN99812627A patent/CN1324367A/zh active Pending
- 1999-08-20 AU AU56905/99A patent/AU751034B2/en not_active Ceased
-
2001
- 2001-03-27 ZA ZA200102489A patent/ZA200102489B/en unknown
-
2010
- 2010-02-19 JP JP2010034833A patent/JP2010150272A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
ZA200102489B (en) | 2002-06-04 |
CZ2001655A3 (cs) | 2001-11-14 |
HUP0103265A2 (hu) | 2002-02-28 |
HUP0103265A3 (en) | 2002-09-30 |
JP4528443B2 (ja) | 2010-08-18 |
AU5690599A (en) | 2000-03-21 |
CN1324367A (zh) | 2001-11-28 |
AU751034B2 (en) | 2002-08-08 |
CA2341810A1 (en) | 2000-03-09 |
JP2010150272A (ja) | 2010-07-08 |
PL346346A1 (en) | 2002-02-11 |
JP2002523518A (ja) | 2002-07-30 |
IL141586A0 (en) | 2002-03-10 |
WO2000012553A1 (en) | 2000-03-09 |
PL204359B1 (pl) | 2010-01-29 |
KR20010079695A (ko) | 2001-08-22 |
EP1105420A1 (en) | 2001-06-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9913490A (pt) | Prosaposina cìclicos e seus usos | |
ES2195970T3 (es) | L-ribavirina y usos de la misma. | |
NO20012774D0 (no) | Preparat og metode hvor det gjöres bruk av eteriske planteoljer | |
DE69927956D1 (de) | Shampoo zusammensetzungen auf basis von silikon | |
FI955866A (fi) | Poishuuhdeltavat vesi öljyssä vedessä -koostumukset | |
MA25279A1 (fr) | Compositions rafraichissantes. | |
ATE289640T1 (de) | Amidofunktionelle aminopolydiorganosiloxane | |
ITRM960810A0 (it) | Composizioni farmaceutiche contenenti ciclosporine o macrolidi | |
DE69210683T2 (de) | Endoskopische, bipolare elektrochirurgische Instrumente | |
BR0109943A (pt) | Composições farmacêuticas | |
FR2705356B1 (fr) | Compositions d'adhésif de pression de silicone. | |
ES2081870T3 (es) | Composiciones polipropilenicas plasto-elasticas. | |
DE69723277D1 (de) | Dampfsterilisierungsanzeigdende zusammensetzungen | |
IT1302347B1 (it) | Procedimento per la produzione diretta di perossido di idrogeno. | |
DE69300694T2 (de) | Desinfizierende Zusammensetzungen. | |
ES2170143T3 (es) | Composiciones que comprenden halofantrina en una forma especial. | |
ITTO930346A0 (it) | Procedimento per la preparazione di derivati taurocolanici. | |
MX9204623A (es) | Compuesto de bis-4-piperidil-fosfita n-metilada. | |
IT1303736B1 (it) | Peptidi derivati da rantes con attivita' anti-hiv. | |
IL139531A0 (en) | Human antithrombin iii, methods for the production thereof and pharmaceutical compositions containing the same | |
PT633928E (pt) | Microrganismos processo de preparacao e utilizacao | |
DE69831737D1 (de) | Neurotrypsin | |
PT1408035E (pt) | Metodo de preparacao de derivativos de 1.5-diaril-3-trifluorometilo-delta2-pirazolinas que sejam racemicos e enanciomericamente puros | |
DE69614552D1 (de) | MODIFIZIERTE ALPHA-D-GLCP-(1,2)-ALPHA-D-Glcp-(1,3)-ALPHA-D-Glcp-ANALOGE | |
GR1002385B (el) | Καθαρη μορφη στρεπτογραμινων, παρασκευη αυτης και φαρμακευτικες συνθεσεις που την περιεχουν. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Transfer |
Free format text: MYLS ACQUISITIONS CORP (US) |
|
TC | Change of name | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A, 6A, 7A E 8A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1911 DE 21/08/2007. |